RAMELTEON

RAMELTEON was reported 7427 times

RAMELTEON is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NO ADVERSE REACTION 7 0.0479
1 INITIAL INSOMNIA 448 0.0436
2 ISCHAEMIC ENTERITIS 4 0.0412
3 EARLY MORNING AWAKENING 4 0.0315
4 GLOSSOPTOSIS 5 0.0228
5 CENTRAL NERVOUS SYSTEM STIMULATION 4 0.0226
6 CENTRAL HYPOTHYROIDISM 7 0.0211
7 MIDDLE INSOMNIA 390 0.0209
8 HANGOVER 70 0.0199
9 EXCITABILITY 5 0.0183
10 UPPER RESPIRATORY TRACT INFLAMMATION 18 0.0150
11 GASTROENTERITIS EOSINOPHILIC 5 0.0147
12 STOMA SITE HYPERGRANULATION 8 0.0127
13 NO ADVERSE DRUG EFFECT 8 0.0118
14 BIPOLAR II DISORDER 4 0.0111
15 HYPERMAGNESAEMIA 7 0.0107
16 INTRACRANIAL TUMOUR HAEMORRHAGE 4 0.0103
17 POOR QUALITY SLEEP 219 0.0102
18 WATER INTOXICATION 5 0.0099
19 SKIN CANDIDA 5 0.0096
20 HEART FAILURE WITH REDUCED EJECTION FRACTION 5 0.0093
21 MARASMUS 14 0.0092
22 DRUG EFFECT PROLONGED 5 0.0091
23 DYSLALIA 6 0.0083
24 THERAPEUTIC RESPONSE INCREASED 7 0.0074
25 MILK ALLERGY 4 0.0072
26 CHOLINERGIC SYNDROME 4 0.0063
27 HYPERCHLORAEMIA 4 0.0063
28 OVARIAN CANCER RECURRENT 10 0.0062
29 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 4 0.0060
30 RECTAL ULCER 7 0.0060
31 LIP EROSION 4 0.0055
32 BRAIN CONTUSION 4 0.0055
33 SPUTUM RETENTION 5 0.0050
34 HYPERCAPNIA 15 0.0050
35 HYPERURICAEMIA 20 0.0049
36 CIRCADIAN RHYTHM SLEEP DISORDER 4 0.0048
37 ABNORMAL DREAMS 133 0.0048
38 GENERALISED ANXIETY DISORDER 7 0.0048
39 SLEEP TALKING 8 0.0047
40 ABNORMAL SLEEP-RELATED EVENT 6 0.0045
41 FEMORAL NECK FRACTURE 22 0.0043
42 NIGHTMARE 146 0.0042
43 CARDIAC FAILURE ACUTE 28 0.0042
44 GASTROINTESTINAL NECROSIS 12 0.0041
45 PARADOXICAL DRUG REACTION 15 0.0041
46 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 24 0.0039
47 PNEUMONIA ASPIRATION 98 0.0039
48 SELF-MEDICATION 16 0.0039
49 NEPHROGENIC ANAEMIA 18 0.0039
50 NO ADVERSE EFFECT 7 0.0039
51 LYMPHANGIOSIS CARCINOMATOSA 4 0.0038
52 ALTERED STATE OF CONSCIOUSNESS 82 0.0038
53 METABOLIC SYNDROME 6 0.0036
54 ILLUSION 6 0.0036
55 PSEUDOMEMBRANOUS COLITIS 8 0.0036
56 PRE-EXISTING CONDITION IMPROVED 22 0.0035
57 SOMNAMBULISM 23 0.0035
58 DRUG EFFECT INCREASED 11 0.0035
59 HYPOPITUITARISM 6 0.0034
60 HYPORESPONSIVE TO STIMULI 4 0.0034
61 SLEEP PARALYSIS 5 0.0034
62 EXCESSIVE EYE BLINKING 5 0.0034
63 ENTEROCOLITIS 19 0.0033
64 STOMACH DISCOMFORT 17 0.0033
65 INFECTIOUS PLEURAL EFFUSION 5 0.0033
66 GASTROSTOMY 5 0.0032
67 HYPERPARATHYROIDISM SECONDARY 8 0.0032
68 SPINAL COMPRESSION FRACTURE 26 0.0031
69 CANCER PAIN 8 0.0031
70 EMBOLIC STROKE 11 0.0031
71 PHYSICAL DECONDITIONING 8 0.0031
72 DISSEMINATED INTRAVASCULAR COAGULATION 43 0.0031
73 CARDIAC FAILURE CHRONIC 13 0.0030
74 HYPERNATRAEMIA 15 0.0030
75 MYOCARDIAL NECROSIS MARKER INCREASED 5 0.0030
76 SMALL INTESTINAL HAEMORRHAGE 6 0.0030
77 PNEUMONIA BACTERIAL 27 0.0029
78 DRUG ERUPTION 52 0.0029
79 DELIRIUM 100 0.0029
80 THERAPEUTIC RESPONSE DELAYED 8 0.0029
81 DIABETIC NEUROPATHY 14 0.0028
82 AORTIC VALVE STENOSIS 5 0.0028
83 SEDATION COMPLICATION 7 0.0027
84 ILEUS PARALYTIC 12 0.0027
85 HEPATIC FUNCTION ABNORMAL 98 0.0026
86 BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0026
87 DRUG DISPENSING ERROR 39 0.0025
88 PULMONARY INFARCTION 6 0.0025
89 ANTICONVULSANT DRUG LEVEL INCREASED 4 0.0025
90 FEELING JITTERY 47 0.0025
91 PSYCHIATRIC SYMPTOM 18 0.0024
92 DEMENTIA ALZHEIMER'S TYPE 4 0.0024
93 HALLUCINATIONS, MIXED 10 0.0024
94 SLEEP TERROR 10 0.0024
95 MALIGNANT PLEURAL EFFUSION 4 0.0024
96 CEREBELLAR INFARCTION 4 0.0024
97 HEPATITIS FULMINANT 7 0.0024
98 ENTERITIS INFECTIOUS 4 0.0023
99 GAZE PALSY 4 0.0023
100 HEPATOSPLENOMEGALY 6 0.0023
101 DEREALISATION 5 0.0023
102 PANIC DISORDER 9 0.0023
103 ALOPECIA AREATA 4 0.0023
104 GASTROINTESTINAL OEDEMA 4 0.0023
105 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23 0.0022
106 RESTLESSNESS 81 0.0022
107 ILEUS 27 0.0022
108 TOXIC ENCEPHALOPATHY 11 0.0022
109 DRUG SCREEN POSITIVE 17 0.0021
110 NARCOLEPSY 4 0.0021
111 SOMNOLENCE 422 0.0021
112 EOSINOPHIL COUNT INCREASED 17 0.0020
113 HYPERSOMNIA 57 0.0020
114 REBOUND ACID HYPERSECRETION 6 0.0020
115 DYSLIPIDAEMIA 10 0.0020
116 HAEMORRHAGIC DIATHESIS 7 0.0020
117 INTERSTITIAL LUNG DISEASE 95 0.0020
118 DIVERTICULAR PERFORATION 4 0.0019
119 NEUROLEPTIC MALIGNANT SYNDROME 23 0.0019
120 LUNG OPACITY 5 0.0019
121 HYPERKINESIA 4 0.0019
122 GALACTORRHOEA 12 0.0019
123 HUMERUS FRACTURE 9 0.0019
124 IMPULSIVE BEHAVIOUR 7 0.0019
125 SKIN EROSION 6 0.0019
126 JAW FRACTURE 4 0.0019
127 CEREBRAL INFARCTION 45 0.0018
128 DECUBITUS ULCER 15 0.0018
129 STOMA SITE DISCHARGE 5 0.0018
130 BIPOLAR I DISORDER 4 0.0018
131 STAPHYLOCOCCAL SEPSIS 9 0.0018
132 PRESCRIBED OVERDOSE 35 0.0018
133 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
134 CHRONIC GASTRITIS 4 0.0018
135 ATELECTASIS 17 0.0018
136 PYELONEPHRITIS 15 0.0017
137 HAEMOTHORAX 5 0.0017
138 BLOOD PROLACTIN INCREASED 8 0.0017
139 EMBOLISM VENOUS 5 0.0016
140 PARKINSONISM 16 0.0016
141 ORGANISING PNEUMONIA 8 0.0016
142 RESTLESS LEGS SYNDROME 29 0.0016
143 CHOLECYSTITIS ACUTE 9 0.0016
144 GENERALISED ERYTHEMA 9 0.0016
145 ENDODONTIC PROCEDURE 4 0.0016
146 ORTHOPNOEA 5 0.0016
147 SCREAMING 10 0.0016
148 FAILURE TO THRIVE 8 0.0015
149 BREAST ENLARGEMENT 5 0.0015
150 PNEUMONIA FUNGAL 6 0.0015
151 IRON DEFICIENCY ANAEMIA 14 0.0015
152 HALLUCINATION, VISUAL 32 0.0015
153 INSOMNIA 402 0.0015
154 MAJOR DEPRESSION 11 0.0015
155 THERAPEUTIC AGENT TOXICITY 5 0.0015
156 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
157 SEDATION 39 0.0015
158 SCHIZOPHRENIA 18 0.0015
159 FEELING DRUNK 11 0.0015
160 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
161 ANORGASMIA 4 0.0015
162 OESOPHAGITIS 16 0.0015
163 PEMPHIGOID 11 0.0015
164 INTESTINAL ISCHAEMIA 8 0.0015
165 PSYCHOMOTOR HYPERACTIVITY 24 0.0014
166 TACHYPHRENIA 5 0.0014
167 HYPERLIPIDAEMIA 17 0.0014
168 SLEEP APNOEA SYNDROME 27 0.0014
169 AORTIC VALVE INCOMPETENCE 6 0.0014
170 ACUTE RESPIRATORY FAILURE 27 0.0014
171 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
172 BLOOD ALBUMIN DECREASED 11 0.0014
173 HYPERTONIC BLADDER 4 0.0014
174 MONOPLEGIA 6 0.0014
175 DYSPNOEA AT REST 4 0.0014
176 SUBARACHNOID HAEMORRHAGE 14 0.0014
177 ENDOCARDITIS 7 0.0014
178 MYASTHENIA GRAVIS 11 0.0014
179 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
180 BLOOD CREATINE INCREASED 6 0.0014
181 HALLUCINATION 102 0.0014
182 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
183 SHOCK HAEMORRHAGIC 11 0.0013
184 POST-TRAUMATIC STRESS DISORDER 9 0.0013
185 HEPATIC STEATOSIS 25 0.0013
186 THINKING ABNORMAL 25 0.0013
187 MITRAL VALVE INCOMPETENCE 15 0.0013
188 HEMIPLEGIA 11 0.0013
189 ACIDOSIS 10 0.0013
190 LARGE INTESTINE POLYP 9 0.0013
191 LARGE INTESTINE PERFORATION 9 0.0013
192 FAMILY STRESS 4 0.0013
193 BIPOLAR DISORDER 14 0.0013
194 DELUSION 20 0.0013
195 HYPOALBUMINAEMIA 10 0.0013
196 MELAENA 28 0.0013
197 EOSINOPHILIC PNEUMONIA 4 0.0013
198 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
199 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0013
200 OBESITY 20 0.0013
201 SPINAL OSTEOARTHRITIS 11 0.0013
202 MALNUTRITION 14 0.0013
203 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
204 PULMONARY ALVEOLAR HAEMORRHAGE 7 0.0012
205 ENURESIS 5 0.0012
206 SUDDEN DEATH 13 0.0012
207 RESPIRATORY DEPRESSION 15 0.0012
208 GOITRE 5 0.0012
209 RENAL IMPAIRMENT 102 0.0012
210 CHRONIC KIDNEY DISEASE 92 0.0012
211 COLON CANCER 18 0.0012
212 DECREASED ACTIVITY 13 0.0012
213 GASTROINTESTINAL PERFORATION 5 0.0012
214 SUICIDAL BEHAVIOUR 5 0.0012
215 SALIVARY HYPERSECRETION 12 0.0012
216 BLOOD LACTATE DEHYDROGENASE INCREASED 19 0.0012
217 SEROTONIN SYNDROME 23 0.0012
218 HALLUCINATION, AUDITORY 19 0.0012
219 LYMPHOCYTE COUNT DECREASED 21 0.0012
220 ECONOMIC PROBLEM 18 0.0012
221 COLITIS ISCHAEMIC 8 0.0012
222 ERYTHEMA MULTIFORME 11 0.0012
223 SLUGGISHNESS 12 0.0012
224 DRUG TOXICITY 16 0.0012
225 BLOOD TESTOSTERONE DECREASED 8 0.0012
226 PERIPHERAL VASCULAR DISORDER 6 0.0012
227 ABNORMAL SENSATION IN EYE 5 0.0012
228 LEFT VENTRICULAR FAILURE 4 0.0012
229 PARANOIA 20 0.0012
230 CERVICAL VERTEBRAL FRACTURE 4 0.0012
231 MANIA 19 0.0012
232 END STAGE RENAL DISEASE 21 0.0012
233 DERMATITIS ACNEIFORM 7 0.0011
234 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
235 PAPULE 8 0.0011
236 DEPRESSIVE SYMPTOM 4 0.0011
237 JAUNDICE CHOLESTATIC 4 0.0011
238 DYSKINESIA 46 0.0011
239 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
240 RHINITIS ALLERGIC 5 0.0011
241 CONJUNCTIVAL HYPERAEMIA 4 0.0011
242 COMPRESSION FRACTURE 6 0.0011
243 SUBDURAL HAEMATOMA 16 0.0011
244 NASAL DRYNESS 7 0.0011
245 FRUSTRATION 4 0.0011
246 FACIAL BONES FRACTURE 4 0.0011
247 CHEILITIS 6 0.0011
248 RHABDOMYOLYSIS 46 0.0011
249 RESPIRATORY FAILURE 80 0.0011
250 EMPHYSEMA 11 0.0011
251 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
252 AMYLASE INCREASED 4 0.0011
253 HYPERACUSIS 4 0.0011
254 EUPHORIC MOOD 11 0.0011
255 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
256 PULMONARY CONGESTION 14 0.0011
257 INTENTIONAL OVERDOSE 68 0.0011
258 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
259 COMMUNICATION DISORDER 4 0.0010
260 VISUAL DISTURBANCE 6 0.0010
261 DIABETIC KETOACIDOSIS 25 0.0010
262 SINUS BRADYCARDIA 10 0.0010
263 EATING DISORDER 22 0.0010
264 VENTRICULAR TACHYCARDIA 17 0.0010
265 APNOEA 8 0.0010
266 PELVIC FRACTURE 8 0.0010
267 TUMOUR LYSIS SYNDROME 9 0.0010
268 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
269 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 9 0.0010
270 CHOLECYSTITIS 12 0.0010
271 ASPIRATION 11 0.0010
272 CEREBRAL ATROPHY 4 0.0010
273 ATRIAL FLUTTER 8 0.0010
274 FLUID INTAKE REDUCED 5 0.0010
275 MUSCLE HAEMORRHAGE 4 0.0010
276 HYPOKALAEMIA 46 0.0010
277 TYPE 1 DIABETES MELLITUS 6 0.0010
278 AGITATION 73 0.0010
279 BLOOD PRESSURE DECREASED 66 0.0010
280 DYSPHORIA 5 0.0010
281 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
282 ASPHYXIA 8 0.0010
283 NERVOUSNESS 51 0.0010
284 CARDIAC FAILURE 78 0.0010
285 HYPERKALAEMIA 34 0.0010
286 VARICOSE VEIN 5 0.0010
287 EXTRAPYRAMIDAL DISORDER 24 0.0010
288 AORTIC DISSECTION 4 0.0010
289 PRODUCT PRESCRIBING ERROR 23 0.0010
290 CONGESTIVE CARDIOMYOPATHY 4 0.0010
291 HAEMATOCRIT DECREASED 19 0.0010
292 BLOOD UREA INCREASED 16 0.0010
293 THIRST 17 0.0010
294 HYPOCALCAEMIA 18 0.0010
295 BLOOD LACTIC ACID INCREASED 5 0.0009
296 LIVER DISORDER 42 0.0009
297 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
298 HYDRONEPHROSIS 7 0.0009
299 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
300 FOOD POISONING 5 0.0009
301 URINARY RETENTION 31 0.0009
302 BRUXISM 5 0.0009
303 ORTHOSTATIC HYPOTENSION 16 0.0009
304 ASCITES 27 0.0009
305 HYDROCEPHALUS 5 0.0009
306 HYPERTHERMIA 7 0.0009
307 SINUS TACHYCARDIA 13 0.0009
308 BACTERIAL INFECTION 17 0.0009
309 DEVICE RELATED INFECTION 14 0.0009
310 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
311 HYPOTHYROIDISM 29 0.0009
312 BLOOD CREATINE PHOSPHOKINASE INCREASED 26 0.0009
313 PRESCRIBED UNDERDOSE 18 0.0009
314 ON AND OFF PHENOMENON 5 0.0009
315 WRONG DRUG ADMINISTERED 8 0.0009
316 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
317 BREAST MASS 6 0.0009
318 OSTEOMYELITIS 16 0.0009
319 IMPAIRED DRIVING ABILITY 10 0.0009
320 C-REACTIVE PROTEIN INCREASED 32 0.0009
321 NEUTROPHIL COUNT INCREASED 9 0.0009
322 EYE MOVEMENT DISORDER 6 0.0009
323 NEUROLOGICAL SYMPTOM 5 0.0009
324 FEBRILE NEUTROPENIA 58 0.0009
325 FEELING ABNORMAL 208 0.0009
326 LYMPHOEDEMA 6 0.0009
327 BLOOD URIC ACID INCREASED 5 0.0009
328 ELECTROCARDIOGRAM QT PROLONGED 31 0.0009
329 FEELING OF DESPAIR 4 0.0009
330 HEPATIC ENCEPHALOPATHY 8 0.0009
331 EPILEPSY 26 0.0008
332 PULMONARY TOXICITY 6 0.0008
333 ASPARTATE AMINOTRANSFERASE INCREASED 45 0.0008
334 ALANINE AMINOTRANSFERASE INCREASED 52 0.0008
335 MENSTRUAL DISORDER 7 0.0008
336 COLITIS MICROSCOPIC 4 0.0008
337 CYTOMEGALOVIRUS INFECTION 14 0.0008
338 HYPONATRAEMIA 47 0.0008
339 TYPE 2 DIABETES MELLITUS 28 0.0008
340 APHAGIA 4 0.0008
341 HYPERCHOLESTEROLAEMIA 8 0.0008
342 DIABETES MELLITUS 63 0.0008
343 ADRENAL INSUFFICIENCY 10 0.0008
344 NOCTURIA 10 0.0008
345 GASTROENTERITIS 12 0.0008
346 NO THERAPEUTIC RESPONSE 10 0.0008
347 IRRITABILITY 49 0.0008
348 CARDIOMEGALY 10 0.0008
349 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
350 HYPOPHOSPHATAEMIA 6 0.0008
351 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
352 LIGAMENT SPRAIN 8 0.0008
353 EXPIRED DRUG ADMINISTERED 4 0.0008
354 SUICIDE ATTEMPT 49 0.0008
355 PLATELET COUNT DECREASED 86 0.0008
356 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 4 0.0008
357 HEPATIC ENZYME ABNORMAL 4 0.0008
358 BLOOD POTASSIUM INCREASED 13 0.0008
359 BREAST TENDERNESS 6 0.0008
360 BLEPHAROSPASM 5 0.0008
361 ANAEMIA 151 0.0008
362 PHOTOPSIA 5 0.0008
363 DRUG TOLERANCE 4 0.0008
364 HUNGER 11 0.0008
365 DISSOCIATION 6 0.0008
366 CEREBRAL HAEMORRHAGE 28 0.0008
367 ENTERITIS 5 0.0008
368 FEAR 21 0.0008
369 DRUG PRESCRIBING ERROR 15 0.0008
370 AGGRESSION 39 0.0008
371 ERECTILE DYSFUNCTION 20 0.0008
372 BRADYCARDIA 41 0.0008
373 INCOHERENT 5 0.0008
374 HIATUS HERNIA 10 0.0008
375 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
376 HYPOGLYCAEMIA 37 0.0008
377 COVID-19 PNEUMONIA 9 0.0008
378 BRAIN NEOPLASM 7 0.0008
379 DYSGRAPHIA 5 0.0008
380 BACTERAEMIA 9 0.0008
381 ABNORMAL BEHAVIOUR 30 0.0008
382 INCONTINENCE 8 0.0008
383 CYTOKINE RELEASE SYNDROME 15 0.0007
384 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
385 CHOLECYSTITIS CHRONIC 5 0.0007
386 TARDIVE DYSKINESIA 21 0.0007
387 PHOTOPHOBIA 14 0.0007
388 RHINITIS 6 0.0007
389 FEMUR FRACTURE 23 0.0007
390 GINGIVITIS 4 0.0007
391 SHOCK 17 0.0007
392 ERYTHEMA OF EYELID 4 0.0007
393 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
394 FAECALOMA 4 0.0007
395 RENAL DISORDER 34 0.0007
396 ASTHENOPIA 4 0.0007
397 PHARYNGITIS 9 0.0007
398 DROOLING 5 0.0007
399 CYSTIC FIBROSIS 4 0.0007
400 VENTRICULAR FIBRILLATION 8 0.0007
401 HEART RATE ABNORMAL 4 0.0007
402 CELLULITIS 36 0.0007
403 PANCREATITIS ACUTE 16 0.0007
404 INFUSION SITE ERYTHEMA 6 0.0007
405 NEUTROPHIL COUNT DECREASED 29 0.0007
406 SUICIDAL IDEATION 65 0.0007
407 PLEURAL EFFUSION 43 0.0007
408 DISORIENTATION 28 0.0007
409 HAND FRACTURE 5 0.0007
410 DISTURBANCE IN ATTENTION 38 0.0007
411 DRUG INEFFECTIVE 927 0.0007
412 DERMATITIS CONTACT 8 0.0007
413 ACUTE KIDNEY INJURY 107 0.0007
414 INFUSION SITE PAIN 9 0.0007
415 INTENTIONAL SELF-INJURY 14 0.0007
416 METASTASES TO LUNG 8 0.0007
417 VISUAL FIELD DEFECT 5 0.0007
418 DYSARTHRIA 26 0.0007
419 DECREASED APPETITE 160 0.0007
420 ANXIETY 196 0.0007
421 FRACTURE 13 0.0007
422 AMENORRHOEA 12 0.0007
423 MENTAL STATUS CHANGES 19 0.0007
424 OEDEMA 37 0.0007
425 ORAL DISORDER 5 0.0007
426 MUSCLE TIGHTNESS 11 0.0007
427 ENERGY INCREASED 4 0.0007
428 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
429 BRADYKINESIA 4 0.0007
430 TREATMENT NONCOMPLIANCE 37 0.0007
431 STOMATITIS 41 0.0007
432 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
433 JAUNDICE 18 0.0007
434 TRANSFUSION 7 0.0007
435 SLEEP DISORDER 47 0.0007
436 HYPOPHAGIA 17 0.0007
437 GANGRENE 4 0.0007
438 IMPAIRED GASTRIC EMPTYING 9 0.0007
439 AKATHISIA 9 0.0007
440 HEPATOCELLULAR CARCINOMA 5 0.0007
441 EXOSTOSIS 6 0.0007
442 RASH GENERALISED 17 0.0007
443 PERIPHERAL COLDNESS 9 0.0007
444 DEPRESSION 149 0.0007
445 RESPIRATORY ARREST 18 0.0007
446 SMALL INTESTINAL OBSTRUCTION 8 0.0006
447 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
448 ANHEDONIA 17 0.0006
449 HAEMOPTYSIS 18 0.0006
450 SEPTIC SHOCK 28 0.0006
451 DYSPHAGIA 61 0.0006
452 RENAL FAILURE 85 0.0006
453 LACERATION 6 0.0006
454 ARTERIOSCLEROSIS 6 0.0006
455 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
456 POISONING 8 0.0006
457 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
458 SEASONAL ALLERGY 9 0.0006
459 MULTIPLE INJURIES 4 0.0006
460 FOOT FRACTURE 12 0.0006
461 RENAL CYST 5 0.0006
462 TRICUSPID VALVE INCOMPETENCE 5 0.0006
463 FALL 209 0.0006
464 SEPSIS 70 0.0006
465 SCIATICA 10 0.0006
466 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
467 PULMONARY HYPERTENSION 13 0.0006
468 OEDEMA PERIPHERAL 76 0.0006
469 GLAUCOMA 12 0.0006
470 SENSORY DISTURBANCE 10 0.0006
471 HEAD DISCOMFORT 11 0.0006
472 ANGER 21 0.0006
473 MENTAL IMPAIRMENT 15 0.0006
474 FIBROMYALGIA 15 0.0006
475 POST PROCEDURAL INFECTION 5 0.0006
476 CONVULSION 35 0.0006
477 DRUG INTERACTION 97 0.0006
478 PSYCHOTIC DISORDER 18 0.0006
479 GASTROENTERITIS VIRAL 11 0.0006
480 BEDRIDDEN 8 0.0006
481 OSTEOPOROSIS 25 0.0006
482 PHOTOSENSITIVITY REACTION 10 0.0006
483 CORONAVIRUS INFECTION 4 0.0006
484 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
485 HEAD INJURY 19 0.0006
486 MULTIPLE ORGAN DYSFUNCTION SYNDROME 17 0.0006
487 CARDIO-RESPIRATORY ARREST 25 0.0006
488 PALPITATIONS 70 0.0006
489 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
490 HYPOAESTHESIA ORAL 9 0.0006
491 RED BLOOD CELL COUNT DECREASED 17 0.0006
492 MEDICATION ERROR 33 0.0006
493 PNEUMONIA 192 0.0006
494 MOOD ALTERED 16 0.0006
495 PHARYNGEAL OEDEMA 9 0.0006
496 PERITONITIS 12 0.0006
497 PROTEINURIA 11 0.0006
498 ENCEPHALITIS 4 0.0006
499 DIPLOPIA 15 0.0006
500 HYSTERECTOMY 5 0.0006
501 PANIC ATTACK 21 0.0006
502 MIGRAINE 55 0.0006
503 FORMICATION 4 0.0006
504 DRUG-INDUCED LIVER INJURY 18 0.0006
505 EXTRASYSTOLES 4 0.0006
506 TREMOR 95 0.0006
507 URINE OUTPUT DECREASED 5 0.0006
508 LOSS OF CONSCIOUSNESS 73 0.0006
509 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
510 LUNG INFILTRATION 5 0.0006
511 PURPURA 5 0.0006
512 MUSCLE TWITCHING 13 0.0006
513 DIVERTICULUM 4 0.0006
514 IRRITABLE BOWEL SYNDROME 12 0.0006
515 HAEMOLYTIC ANAEMIA 5 0.0006
516 DIZZINESS 278 0.0006
517 SKIN LACERATION 6 0.0006
518 MENTAL DISORDER 24 0.0006
519 URINARY TRACT INFECTION 94 0.0006
520 PYREXIA 190 0.0005
521 HYPERGLYCAEMIA 20 0.0005
522 APATHY 8 0.0005
523 OVERDOSE 118 0.0005
524 GASTROOESOPHAGEAL REFLUX DISEASE 44 0.0005
525 STAPHYLOCOCCAL INFECTION 18 0.0005
526 HEART RATE INCREASED 54 0.0005
527 TOOTH FRACTURE 6 0.0005
528 DYSURIA 20 0.0005
529 DENTAL CARIES 6 0.0005
530 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
531 CEREBRAL DISORDER 4 0.0005
532 STEVENS-JOHNSON SYNDROME 12 0.0005
533 HYPOXIA 19 0.0005
534 PERSONALITY CHANGE 5 0.0005
535 DEMENTIA 15 0.0005
536 BLOOD CHOLESTEROL INCREASED 25 0.0005
537 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
538 EPISTAXIS 40 0.0005
539 FACE OEDEMA 9 0.0005
540 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
541 ORAL CANDIDIASIS 7 0.0005
542 HAEMODYNAMIC INSTABILITY 4 0.0005
543 DEHYDRATION 70 0.0005
544 INCREASED APPETITE 10 0.0005
545 AMNESIA 34 0.0005
546 BOWEL MOVEMENT IRREGULARITY 4 0.0005
547 AFFECT LABILITY 5 0.0005
548 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
549 PERICARDIAL EFFUSION 12 0.0005
550 OSTEOARTHRITIS 22 0.0005
551 PANCYTOPENIA 29 0.0005
552 BLOOD BILIRUBIN INCREASED 14 0.0005
553 ATRIOVENTRICULAR BLOCK 4 0.0005
554 ELECTROLYTE IMBALANCE 6 0.0005
555 DIZZINESS POSTURAL 5 0.0005
556 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 12 0.0005
557 MULTIPLE ALLERGIES 4 0.0005
558 COELIAC DISEASE 5 0.0005
559 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
560 HEPATOMEGALY 5 0.0005
561 BODY TEMPERATURE DECREASED 5 0.0005
562 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
563 RENAL INJURY 15 0.0005
564 LETHARGY 29 0.0005
565 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
566 MYOCLONUS 6 0.0005
567 ROAD TRAFFIC ACCIDENT 21 0.0005
568 DRUG EFFECT DECREASED 27 0.0005
569 WRIST FRACTURE 6 0.0005
570 BLOOD POTASSIUM DECREASED 15 0.0005
571 HAEMOGLOBIN DECREASED 51 0.0005
572 RASH MACULO-PAPULAR 11 0.0005
573 FEEDING DISORDER 10 0.0005
574 CONSTIPATION 107 0.0005
575 THERAPEUTIC RESPONSE UNEXPECTED 22 0.0005
576 WHITE BLOOD CELL COUNT DECREASED 53 0.0005
577 MEMORY IMPAIRMENT 67 0.0005
578 ARRHYTHMIA 23 0.0005
579 SEIZURE 56 0.0005
580 DYSGEUSIA 36 0.0005
581 CARDIAC ARREST 40 0.0005
582 HYPERBILIRUBINAEMIA 5 0.0005
583 VENTRICULAR EXTRASYSTOLES 5 0.0005
584 LIVER FUNCTION TEST ABNORMAL 14 0.0005
585 TENDERNESS 5 0.0005
586 LIMB INJURY 13 0.0005
587 INTENTIONAL DRUG MISUSE 10 0.0005
588 DEEP VEIN THROMBOSIS 31 0.0005
589 BRAIN OEDEMA 6 0.0005
590 HAEMATEMESIS 12 0.0005
591 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
592 PULMONARY MASS 7 0.0005
593 COMPLETED SUICIDE 39 0.0005
594 HAEMATURIA 16 0.0005
595 HYPERHIDROSIS 60 0.0005
596 ANOREXIA 6 0.0005
597 NIGHT SWEATS 15 0.0005
598 LACTIC ACIDOSIS 15 0.0005
599 MYOPATHY 4 0.0005
600 PRURITUS GENERALISED 10 0.0005
601 CARDIAC MURMUR 4 0.0005
602 OSTEOPENIA 7 0.0005
603 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
604 CHOLELITHIASIS 15 0.0005
605 DYSMENORRHOEA 6 0.0005
606 WITHDRAWAL SYNDROME 19 0.0005
607 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
608 EJECTION FRACTION DECREASED 7 0.0004
609 TACHYCARDIA 40 0.0004
610 SWOLLEN TONGUE 14 0.0004
611 MYOSITIS 4 0.0004
612 CYANOSIS 7 0.0004
613 OXYGEN SATURATION DECREASED 25 0.0004
614 DRY MOUTH 36 0.0004
615 THROAT TIGHTNESS 12 0.0004
616 VERTIGO 27 0.0004
617 STATUS EPILEPTICUS 5 0.0004
618 REBOUND EFFECT 5 0.0004
619 PULMONARY EMBOLISM 42 0.0004
620 PNEUMOTHORAX 7 0.0004
621 MYOCARDIAL ISCHAEMIA 5 0.0004
622 URINARY INCONTINENCE 13 0.0004
623 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
624 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
625 CARDIAC FAILURE CONGESTIVE 35 0.0004
626 PANCREATITIS 23 0.0004
627 RESPIRATORY DISORDER 13 0.0004
628 GRAND MAL CONVULSION 4 0.0004
629 NAUSEA 342 0.0004
630 HYPOMAGNESAEMIA 6 0.0004
631 COORDINATION ABNORMAL 6 0.0004
632 EYELID OEDEMA 5 0.0004
633 VASCULITIS 5 0.0004
634 BLOOD CREATININE INCREASED 28 0.0004
635 CARPAL TUNNEL SYNDROME 6 0.0004
636 APPENDICITIS 4 0.0004
637 UNRESPONSIVE TO STIMULI 11 0.0004
638 LIVER FUNCTION TEST INCREASED 9 0.0004
639 PARALYSIS 6 0.0004
640 ANGINA PECTORIS 12 0.0004
641 GASTROINTESTINAL HAEMORRHAGE 35 0.0004
642 CARDIOGENIC SHOCK 6 0.0004
643 HEADACHE 262 0.0004
644 CONTUSION 40 0.0004
645 MYELODYSPLASTIC SYNDROME 6 0.0004
646 MUSCULAR WEAKNESS 47 0.0004
647 HYPOKINESIA 6 0.0004
648 CRYING 15 0.0004
649 BURSITIS 5 0.0004
650 EAR PAIN 8 0.0004
651 NEURALGIA 10 0.0004
652 UNDERDOSE 30 0.0004
653 ATRIAL FIBRILLATION 40 0.0004
654 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
655 MALIGNANT NEOPLASM PROGRESSION 42 0.0004
656 ORAL HERPES 8 0.0004
657 CYSTITIS 13 0.0004
658 LUNG DISORDER 20 0.0004
659 MUSCLE SPASTICITY 5 0.0004
660 COGNITIVE DISORDER 19 0.0004
661 VOMITING 191 0.0004
662 BALANCE DISORDER 35 0.0004
663 DISABILITY 8 0.0004
664 HYPERTENSION 85 0.0004
665 SPEECH DISORDER 21 0.0004
666 HYPOTONIA 4 0.0004
667 COMA 19 0.0004
668 BLOOD PRESSURE INCREASED 61 0.0004
669 METASTASES TO LIVER 7 0.0004
670 DYSPNOEA EXERTIONAL 15 0.0004
671 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
672 COLITIS 15 0.0004
673 HYPOTHERMIA 4 0.0004
674 CONDITION AGGRAVATED 120 0.0004
675 BONE MARROW FAILURE 8 0.0004
676 EYELID PTOSIS 4 0.0004
677 DRY THROAT 4 0.0004
678 GALLBLADDER DISORDER 7 0.0004
679 TINNITUS 18 0.0004
680 THYROID DISORDER 6 0.0004
681 RIB FRACTURE 8 0.0004
682 LYMPHOMA 6 0.0004
683 MUSCULOSKELETAL CHEST PAIN 6 0.0004
684 ANKLE FRACTURE 6 0.0004
685 TOOTHACHE 7 0.0004
686 HAEMATOMA 10 0.0004
687 HYPOTENSION 77 0.0004
688 HERPES ZOSTER 22 0.0004
689 GASTRITIS 10 0.0004
690 TOOTH INFECTION 5 0.0004
691 DYSSTASIA 11 0.0004
692 INTENTIONAL PRODUCT USE ISSUE 33 0.0004
693 BREAST PAIN 4 0.0004
694 JOINT INJURY 8 0.0004
695 IMPAIRED WORK ABILITY 8 0.0004
696 FATIGUE 291 0.0004
697 TOXICITY TO VARIOUS AGENTS 63 0.0004
698 HEPATIC CIRRHOSIS 7 0.0004
699 WEIGHT INCREASED 83 0.0004
700 PRESYNCOPE 9 0.0004
701 MUSCULOSKELETAL DISORDER 7 0.0004
702 TACHYPNOEA 5 0.0004
703 PNEUMONITIS 10 0.0004
704 ENCEPHALOPATHY 9 0.0004
705 HEPATIC FAILURE 11 0.0004
706 OSTEONECROSIS OF JAW 9 0.0004
707 APPLICATION SITE RASH 5 0.0004
708 THERAPEUTIC RESPONSE DECREASED 22 0.0004
709 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
710 DRUG LEVEL INCREASED 6 0.0004
711 HAEMATOCHEZIA 20 0.0004
712 ERUCTATION 7 0.0004
713 GAIT DISTURBANCE 69 0.0004
714 COAGULOPATHY 6 0.0004
715 FEELING COLD 10 0.0004
716 FEELING HOT 22 0.0004
717 CHOKING 7 0.0004
718 BLOOD TEST ABNORMAL 5 0.0004
719 CANDIDA INFECTION 6 0.0004
720 DEVICE OCCLUSION 5 0.0004
721 DIARRHOEA 229 0.0004
722 PAIN IN JAW 10 0.0004
723 DIALYSIS 5 0.0004
724 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
725 SCAR 6 0.0004
726 NEUROPATHY PERIPHERAL 33 0.0003
727 HYPERTHYROIDISM 5 0.0003
728 MOOD SWINGS 11 0.0003
729 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
730 UNEVALUABLE EVENT 26 0.0003
731 MOVEMENT DISORDER 11 0.0003
732 EOSINOPHILIA 6 0.0003
733 MALAISE 150 0.0003
734 INCORRECT DOSE ADMINISTERED 78 0.0003
735 THROMBOCYTOPENIA 38 0.0003
736 ACUTE MYOCARDIAL INFARCTION 10 0.0003
737 CARDIOMYOPATHY 5 0.0003
738 TOOTH LOSS 7 0.0003
739 WEIGHT DECREASED 94 0.0003
740 ASTHENIA 126 0.0003
741 ACCIDENT 4 0.0003
742 MUSCLE RIGIDITY 4 0.0003
743 CONFUSIONAL STATE 54 0.0003
744 DERMATITIS 7 0.0003
745 PELVIC PAIN 6 0.0003
746 RENAL FAILURE ACUTE 14 0.0003
747 INJURY 23 0.0003
748 NEPHROLITHIASIS 15 0.0003
749 CYTOPENIA 4 0.0003
750 RHINORRHOEA 21 0.0003
751 BRONCHITIS 24 0.0003
752 ABASIA 8 0.0003
753 AGRANULOCYTOSIS 6 0.0003
754 CYST 4 0.0003
755 NECK PAIN 18 0.0003
756 PRODUCT DISPENSING ERROR 7 0.0003
757 LEUKOPENIA 16 0.0003
758 HOSPITALISATION 49 0.0003
759 INTESTINAL OBSTRUCTION 12 0.0003
760 BLOOD SODIUM DECREASED 6 0.0003
761 PRODUCTIVE COUGH 15 0.0003
762 HEART RATE DECREASED 11 0.0003
763 METABOLIC ACIDOSIS 10 0.0003
764 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 63 0.0003
765 LYMPHADENOPATHY 11 0.0003
766 ANAPHYLACTIC SHOCK 8 0.0003
767 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
768 BACK PAIN 72 0.0003
769 SYNCOPE 31 0.0003
770 HEART RATE IRREGULAR 7 0.0003
771 SKIN ULCER 8 0.0003
772 DYSTONIA 6 0.0003
773 HAEMORRHOIDS 6 0.0003
774 PLASMA CELL MYELOMA 12 0.0003
775 MUCOSAL INFLAMMATION 8 0.0003
776 LABORATORY TEST ABNORMAL 9 0.0003
777 IMMUNE SYSTEM DISORDER 4 0.0003
778 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
779 DEPRESSED MOOD 16 0.0003
780 UPPER LIMB FRACTURE 6 0.0003
781 MALIGNANT MELANOMA 4 0.0003
782 NO ADVERSE EVENT 54 0.0003
783 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
784 ABDOMINAL DISTENSION 31 0.0003
785 CHEST PAIN 55 0.0003
786 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
787 MUSCLE SPASMS 54 0.0003
788 PALLOR 8 0.0003
789 HYPOAESTHESIA 44 0.0003
790 CIRCULATORY COLLAPSE 5 0.0003
791 METRORRHAGIA 5 0.0003
792 ABDOMINAL PAIN 68 0.0003
793 LUNG NEOPLASM MALIGNANT 12 0.0003
794 EMOTIONAL DISORDER 9 0.0003
795 MUSCULOSKELETAL DISCOMFORT 5 0.0003
796 PULMONARY OEDEMA 13 0.0003
797 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
798 CHILLS 34 0.0003
799 MULTI-ORGAN FAILURE 5 0.0003
800 RASH 126 0.0003
801 POLLAKIURIA 12 0.0003
802 BONE DENSITY DECREASED 9 0.0003
803 HAEMORRHAGE 30 0.0003
804 BLISTER 16 0.0003
805 OFF LABEL USE 249 0.0003
806 VISION BLURRED 39 0.0003
807 ASTHMA 32 0.0003
808 DYSPNOEA 159 0.0003
809 HEPATIC ENZYME INCREASED 19 0.0003
810 NASOPHARYNGITIS 51 0.0003
811 GASTRIC CANCER 7 0.0003
812 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
813 FLUID RETENTION 14 0.0003
814 HYPERSENSITIVITY 51 0.0003
815 BONE DISORDER 5 0.0003
816 COVID-19 48 0.0003
817 ACCIDENTAL OVERDOSE 10 0.0003
818 ABDOMINAL PAIN UPPER 56 0.0003
819 MULTIPLE SCLEROSIS 13 0.0003
820 VISUAL ACUITY REDUCED 9 0.0003
821 VIRAL INFECTION 9 0.0003
822 DISEASE PROGRESSION 32 0.0003
823 CONJUNCTIVITIS 5 0.0003
824 INFLUENZA 30 0.0003
825 RESPIRATORY TRACT INFECTION 7 0.0003
826 SNEEZING 6 0.0003
827 MUSCULOSKELETAL PAIN 14 0.0003
828 GASTRIC ULCER 5 0.0003
829 PRURITUS 100 0.0003
830 LIMB DISCOMFORT 8 0.0003
831 PAIN IN EXTREMITY 76 0.0003
832 LUNG INFECTION 4 0.0003
833 ACUTE MYELOID LEUKAEMIA 4 0.0003
834 BASAL CELL CARCINOMA 4 0.0003
835 RECTAL HAEMORRHAGE 11 0.0003
836 NASAL CONGESTION 15 0.0003
837 KIDNEY INFECTION 5 0.0003
838 CHEST DISCOMFORT 26 0.0003
839 SINUSITIS 26 0.0003
840 DIVERTICULITIS 7 0.0003
841 HOT FLUSH 19 0.0003
842 INFLAMMATION 13 0.0003
843 PAIN 154 0.0003
844 BLOOD PRESSURE FLUCTUATION 6 0.0002
845 COUGH 70 0.0002
846 SPINAL FRACTURE 5 0.0002
847 FLATULENCE 14 0.0002
848 TASTE DISORDER 5 0.0002
849 BACK DISORDER 4 0.0002
850 SWELLING FACE 16 0.0002
851 IMPAIRED HEALING 8 0.0002
852 EXPIRED PRODUCT ADMINISTERED 8 0.0002
853 NEEDLE ISSUE 7 0.0002
854 FLUSHING 24 0.0002
855 WHEEZING 14 0.0002
856 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
857 EMOTIONAL DISTRESS 28 0.0002
858 EYE PAIN 13 0.0002
859 NEOPLASM PROGRESSION 8 0.0002
860 COLD SWEAT 4 0.0002
861 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
862 MENSTRUATION IRREGULAR 6 0.0002
863 ERYTHEMA 46 0.0002
864 BLOOD GLUCOSE INCREASED 42 0.0002
865 DYSPHONIA 13 0.0002
866 MYELOSUPPRESSION 8 0.0002
867 BONE PAIN 13 0.0002
868 CHROMATURIA 5 0.0002
869 LEUKOCYTOSIS 4 0.0002
870 DRY EYE 11 0.0002
871 DRUG EFFECT INCOMPLETE 8 0.0002
872 CATARACT 13 0.0002
873 MYALGIA 37 0.0002
874 ARTHRITIS 17 0.0002
875 GENERAL PHYSICAL HEALTH DETERIORATION 25 0.0002
876 WOUND 6 0.0002
877 BURNING SENSATION 15 0.0002
878 CARDIAC DISORDER 20 0.0002
879 EYE DISORDER 7 0.0002
880 PRODUCT USE ISSUE 40 0.0002
881 GASTROINTESTINAL DISORDER 19 0.0002
882 OCULAR HYPERAEMIA 10 0.0002
883 FUNGAL INFECTION 7 0.0002
884 MOBILITY DECREASED 15 0.0002
885 LOWER LIMB FRACTURE 4 0.0002
886 OROPHARYNGEAL PAIN 19 0.0002
887 DRUG WITHDRAWAL SYNDROME 18 0.0002
888 SURGERY 12 0.0002
889 GASTRIC DISORDER 7 0.0002
890 MENORRHAGIA 4 0.0002
891 AGEUSIA 5 0.0002
892 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
893 THROMBOSIS 16 0.0002
894 CARDIOVASCULAR DISORDER 5 0.0002
895 MYOCARDIAL INFARCTION 34 0.0002
896 DRUG RESISTANCE 5 0.0002
897 DYSPEPSIA 19 0.0002
898 DEAFNESS 5 0.0002
899 ECZEMA 10 0.0002
900 URTICARIA 32 0.0002
901 MOUTH ULCERATION 4 0.0002
902 ADVERSE DRUG REACTION 17 0.0002
903 EAR INFECTION 5 0.0002
904 BLOOD GLUCOSE DECREASED 9 0.0002
905 HIP FRACTURE 6 0.0002
906 INFECTION 27 0.0002
907 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
908 RASH PRURITIC 10 0.0002
909 INFLUENZA LIKE ILLNESS 15 0.0002
910 ANAPHYLACTIC REACTION 10 0.0002
911 DISCOMFORT 11 0.0002
912 LIP SWELLING 6 0.0002
913 GAIT INABILITY 6 0.0002
914 GLOSSODYNIA 4 0.0002
915 SKIN EXFOLIATION 15 0.0002
916 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
917 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
918 NEUTROPENIA 24 0.0002
919 APPLICATION SITE PRURITUS 4 0.0002
920 SKIN DISCOLOURATION 8 0.0002
921 ABDOMINAL DISCOMFORT 29 0.0002
922 PARAESTHESIA 27 0.0002
923 INTENTIONAL PRODUCT MISUSE 15 0.0002
924 CEREBROVASCULAR ACCIDENT 29 0.0002
925 VISUAL IMPAIRMENT 21 0.0002
926 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
927 INFUSION RELATED REACTION 11 0.0002
928 APHASIA 5 0.0002
929 ARTHRALGIA 68 0.0002
930 DRUG DOSE OMISSION 27 0.0002
931 INJECTION SITE RASH 5 0.0002
932 ADVERSE EVENT 15 0.0002
933 GYNAECOMASTIA 5 0.0002
934 MUSCULOSKELETAL STIFFNESS 14 0.0002
935 RHEUMATOID ARTHRITIS 18 0.0002
936 SKIN IRRITATION 7 0.0002
937 JOINT STIFFNESS 4 0.0002
938 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
939 SKIN DISORDER 5 0.0001
940 ILL-DEFINED DISORDER 9 0.0001
941 ALOPECIA 29 0.0001
942 PRODUCT QUALITY ISSUE 20 0.0001
943 RASH ERYTHEMATOUS 7 0.0001
944 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
945 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
946 DEATH 121 0.0001
947 INTENTIONAL DOSE OMISSION 4 0.0001
948 EYE IRRITATION 8 0.0001
949 SWELLING 13 0.0001
950 DEVICE DISLOCATION 6 0.0001
951 DRUG DEPENDENCE 22 0.0001
952 DRUG INTOLERANCE 13 0.0001
953 THERAPY NON-RESPONDER 6 0.0001
954 TREATMENT FAILURE 11 0.0001
955 LACRIMATION INCREASED 4 0.0001
956 CORONARY ARTERY DISEASE 4 0.0001
957 DRUG ADMINISTRATION ERROR 4 0.0001
958 PRODUCT DOSE OMISSION ISSUE 38 0.0001
959 DISEASE RECURRENCE 6 0.0001
960 COLORECTAL CANCER 6 0.0001
961 INJECTION SITE BRUISING 10 0.0001
962 ABORTION SPONTANEOUS 5 0.0001
963 PRODUCT SUBSTITUTION ISSUE 7 0.0001
964 JOINT SWELLING 14 0.0001
965 VAGINAL HAEMORRHAGE 5 0.0001
966 THROAT IRRITATION 5 0.0001
967 ARTHROPATHY 6 0.0001
968 EYE SWELLING 4 0.0001
969 ILLNESS 11 0.0001
970 ACNE 8 0.0001
971 DEVICE ISSUE 9 0.0001
972 BLINDNESS 4 0.0001
973 THERAPY INTERRUPTED 7 0.0001
974 THERAPY CESSATION 5 0.0001
975 DRY SKIN 13 0.0001
976 INJECTION SITE ERYTHEMA 12 0.0001
977 EXPOSURE DURING PREGNANCY 6 0.0001
978 DERMATITIS ATOPIC 5 0.0001
979 HYPOACUSIS 4 0.0001
980 PERIPHERAL SWELLING 14 0.0001
981 NEOPLASM MALIGNANT 6 0.0001
982 COLITIS ULCERATIVE 4 0.0001
983 BREAST CANCER 8 0.0001
984 SKIN BURNING SENSATION 6 0.0001
985 PSORIASIS 10 0.0001
986 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
987 DRUG ABUSE 6 0.0001
988 INJECTION SITE PAIN 18 0.0001
989 INJECTION SITE REACTION 4 0.0001
990 PRODUCT STORAGE ERROR 5 0.0001
991 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000